Department Introduction

Rheumatology and Immunology | Our Speciality

:::

Our Speciality

Management of Refractory Autoinflammatory Diseases (Primarily Adult-Onset Still’s Disease/AOSD)

▪ Provides a comprehensive one-stop medical service for AOSD.
▪ SNQ National Quality Certification (2022-2024).
▪ 35 SCI-indexed publications—the highest number of single-center publications globally.
▪ Research findings have been widely cited over 1,500 times and have received four patents (two from the United States and two from Taiwan).

Innovative allogeneic adipose-derived stem cell therapy for Connective Tissue Diseases with Interstitial Lung Disease (ILD)

▪ Conducting a Phase I/IIa clinical trial, which has been approved by Taiwan’s Ministry of Health and Welfare.

Personalized Screening and Prevention for Rheumatic Disease Comorbidities

▪ A patient-centered case management system with Risk Management Plans (RMPs), ensuring zero adverse events in the past 10 years.
▪ 20 SCI-indexed publications.
▪ Two patents (one in the United States and one in Taiwan).
▪ Developing the first Asia-Pacific guidelines for RA comorbidity prevention and management, cited 37 times in the past three years.

Stay connected with CMUH
How to get to CMUH the map of hospital
百度 搜狗 360搜索 香港前特首梁振英女儿去世 终年33岁 美联储官员:预计今年美国经济增长将明显低于预期 融合植物210:究极诸神剑仙杨桃! 男子在高速上开智能驾驶睡觉,超速行驶百公里,被记 6 分罚 400 元,过度依赖「辅助驾驶」有多危险? 比亚迪唐L上市22.98万元起

      <code id='0fe74'></code><style id='52a20'></style>
    • <acronym id='a1ef8'></acronym>
      <center id='1b13e'><center id='72d7b'><tfoot id='72ee5'></tfoot></center><abbr id='470af'><dir id='6d6c9'><tfoot id='49d71'></tfoot><noframes id='43513'>

    • <optgroup id='04bb2'><strike id='dfd2b'><sup id='4f842'></sup></strike><code id='f345c'></code></optgroup>
        1. <b id='c97ba'><label id='079cd'><select id='177cb'><dt id='97df5'><span id='958dc'></span></dt></select></label></b><u id='96019'></u>
          <i id='10f0e'><strike id='c2d52'><tt id='82211'><pre id='b84e3'></pre></tt></strike></i>